Investigations into the Hypothesis of Transgenic Cannabis

Journal of Forensic Sciences

Volumn 57, Issue 3, 2012, Pages 718-721

  Cascini, Fidelia ^a,b  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

Cannabis; Delta 9 tetrahydrocannabinol; Forensic science; Marijuana; Potency; Tetrahydrocannabinol; Transgenic

Indexed keywords

EID: 84860143982     PISSN: 00221198     EISSN: 15564029     Source Type: Journal    
DOI: 10.1111/j.1556-4029.2011.02021.x     Document Type: Article

References (23)

1. Fellermeier M, Eisenreich W, Bacher A, Zenk MH. Biosynthesis of cannabinoids. Incorporation experiments with C13-labeled glucoses. Eur J Biochem 2001;268:1596-604.
2. Raharjo TJ, Chang WT, Verberne MC, Peltenburg-Looman AM, Linthorst HJ, Verpoorte R. Cloning and over-expression of a cDNA encoding a polyketide synthase from Cannabis sativa. Plant Physiol Biochem 2004;42:291-7.
3. Thakur GA, Duclos RI, Makriyannis A. Natural cannabinoids: templates for drug discovery. Life Sci 2005;78:454-66.
4. ElSohly MA, Ross SA, Mehmedic Z, Arafat R, Yi B, Banahan BF III. Potency trends of Δ9-THC and other cannabinoids in confiscated marijuana from 1980-1997. J Forensic Sci 2000;45:24-30.
5. Poulsen HA, Sutherland GJ. The potency of cannabis in New Zealand from 1976 to 1996. Sci Justice 2000;40:171-6.
6. Pitts JE, O'Neil PJ, Leggo KP. Variation in the THC content of illicit imported cannabis products-1984-1989. J Pharm Pharmacol 1990;42:817-20.
7. Felby S, Nielsen E. Cannabinoid content of cannabis grown on the Danish island of Bornholm. Bull Narc 1985;37:87-94.
8. Pijlman FT, Rigter SM, Hoek J, Goldschmidt HM, Niesink RJ. Strong increase in total delta-THC in cannabis preparations sold in Dutch coffee shops. Addict Biol 2005;10:171-80.
9. Licata M, Verri P, Bedusci G. δ9 THC content in illicit cannabis products over the period 1997-2004 (first four months). Ann Ist Super Sanità 2005;41:483-5.
10. Bone C, Waldron SJ. New trends in illicit cannabis cultivation in the United Kingdom of Great Britain and Northern Ireland. Narc 19971998;49(1, 2)/50(1, 2):117.
11. Szendrei K. Cannabis as an illicit crop: recent developments in cultivation and product quality. Bull Narc 19971998;XLIX/L:1-21.
12. McCaskill D, Croteau R. Strategies for bioengineering the development and metabolism of glandular tissues in plants. Nat Biotech 1999;17:31-6.
13. Sirikantaramas S, Morimoto S, Shoyama Y, Ishikawa Y, Wada Y, Shoyama Y, et al. The gene controlling marijuana psychoactivity. J Biol Chem 2004;279:39767-74.
14. Sirikantaramas S, Taura F, Tanaka Y, Ishikawa Y, Morimoto S, Shoyama Y. Tetrahydrocannabinolic acid synthase, the enzyme controlling marijuana psychoactivity, is secreted into the storage cavity of the glandular trichomes. Plant Cell Physiol 2005;46:1578-82.
15. Terzi V. RAPD markers for fingerprinting barley, oat and triticale varieties. J Genet Breed 1997;51:115-20.
16. De Meijer E, Bagatta M, Carboni A, Crucitti P, Moliterni VM, Ranalli P, et al. The inheritance of chemical phenotype in Cannabis sativa L. Genetics 2003;163:335-46.
17. Anklam E, Gadani F, Heinze P, Pijnenburg H, Van Den Eede G. Analytical methods for detection and determination of genetically modified organisms in agricultural crops and plant-derived food products. Eur Food Res Technol 2002;214:3-26.
18. Vollenhofer S, Burg K, Schmidt J, Kroath H. Genetically modified organisms in food: screening and specific detection by polymerase chain reaction. J Agric Food Chem 1999;47:5038-43.
19. Wolf C, Scherzinger M, Wurz A, Pauli U, Hübner P, Lüthy J. Detection of cauliflower mosaic virus by the polymerase chain reaction: testing of food component for false-positive 35S-promoter screening results. Eur Food Res Technol 2000;210:367-72.
20. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acid Res 1997;25:3389-402.
21. Hall W. Is cannabis use psychotogenic? Lancet 2006;367:193-5.
22. Ludica CR, Riegel AC, Hoffman AF. Marijuana and cannabinoid regulation of brain reward circuits. Br J Pharmacol 2004;143:227-34.
23. Steffens S, Veillard NR, Arnaud C, Pelli G, Burger F, Staub C, et al. Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. Nature 2005;434:782-6.